血液および血液成分の世界市場レポート 2025年

血液および血液成分市場規模は、今後数年間で力強い成長が見込まれます。2029年には535億6,000万米ドルに成長し、CAGRは5.5%となります。予測期間の成長は、慢性疾患の増加、政府の取り組み、全血の需要増に起因しています。予測期間における主な動向としては、他のプレイヤーとの協業の重視、革新的な製品の発売、研究開発（R&D）活動の重視、血液および血液成分の汚染を回避するためのIoTベースの製品の使用、輸血管理の重視などが挙げられます。

血液および血液成分市場は、外傷や交通事故の増加によって推進されています。出血のような外傷は血液量を著しく減少させ、身体はそれをすぐに補うことができません。さらに、交通事故ではかなりの出血が生じ、早急な回復が必要となります。このような状況では、患者に血液やその成分を輸血する必要があります。たとえば、オーストラリアの政府機関である運輸事故委員会は2023年、ビクトリア州の道路で295人が命を落としたと報告しており、これは2022年と比較して22.4％の増加（死亡者数が54人増加）にあたる。また、死亡事故件数は261件で、前年の239件から22件（9％）増加しました。疾病の有病率の上昇、交通事故や外傷の増加が血液需要を押し上げ、市場の成長を促進しています。

出血性疾患の急増は、血液および血液成分市場の拡大をさらに促進すると予想されます。血友病などの疾患を含む出血性疾患は、血液凝固障害を伴い、軽傷や自然出血であっても過度の出血や長引く出血を引き起こします。血液とその成分は、赤血球、血小板、凝固因子などの必須元素を供給することにより、これらの疾患の治療において極めて重要な役割を果たしています。これらの成分を輸血することで、患者に不足している、あるいは機能不全に陥っている成分を補ったり、置き換えたりすることができ、それによって血液凝固能や全体的な健康状態を向上させることができます。例えば、2023年7月に米国疾病予防管理センター（CDC）が発表したところによると、血友病Aは米国の男性出生数約5,000人に1人の割合で発症しており、毎年400人の血友病Aの赤ちゃんが誕生していると推定されています。さらに、現在の推定では、米国では30,000人から33,000人の男性が血友病とともに生活しているとされています。したがって、出血性疾患の罹患率の上昇は、血液および血液成分市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界血液および血液成分PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の血液および血液成分市場：成長率分析
• 世界の血液および血液成分市場の実績：規模と成長, 2019-2024
• 世界の血液および血液成分市場の予測：規模と成長, 2024-2029, 2034F
• 世界血液および血液成分総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血液および血液成分市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全血
• 血液成分
• 世界の血液および血液成分市場血液成分別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 赤血球
• 血小板
• プラズマ
• 白血球
• 世界の血液および血液成分市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• その他
• 世界の血液および血液成分市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 貧血
• 外傷と手術
• がん治療
• 出血性疾患
• 世界の血液および血液成分市場全血の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドナー全血
• 自己全血
• 世界の血液および血液成分市場血液成分の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 赤血球（RBC）
• 血小板
• プラズマ
• 白血球（WBC）

第7章 地域別・国別分析

• 世界の血液および血液成分市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の血液および血液成分市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血液および血液成分市場：競合情勢
• 血液および血液成分市場：企業プロファイル
  • American Red Cross Overview, Products and Services, Strategy and Financial Analysis
  • The Japanese Red Cross Society Overview, Products and Services, Strategy and Financial Analysis
  • Canadian Blood Services Overview, Products and Services, Strategy and Financial Analysis
  • Australian Red Cross Overview, Products and Services, Strategy and Financial Analysis
  • and Vitalant Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• SANQUIN BLOOD SUPPLY FOUNDATION
• New York Blood Center
• Blood Bank of Alaska
• Blood Centers of America
• Xinjiang Deyuan Bioengineering
• Harbin Pacific Biopharmaceutical
• Southern Shuanglin Bio-Pharmacy
• Beijing Tiantan Biological Products
• Shanghai RAAS Blood Products
• China Biologic Products
• Hualan Biological Engineering
• Biotest AG
• Lorne Laboratories UK
• LMB Germany
• Bio Products Laboratory Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血液および血液成分市場2029：新たな機会を提供する国
• 血液および血液成分市場2029：新たな機会を提供するセグメント
• 血液および血液成分市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Blood and Blood Components refer to the various elements of blood, including red blood cells, white blood cells, platelets, and plasma, that are separated for medical applications. These components are utilized to address a range of conditions such as anemia, clotting disorders, and immune deficiencies. Each component is transfused according to the specific requirements of the patient for their recovery.

Key products in the blood and blood components market include whole blood and its various components. Whole blood, derived from standard blood donations, is employed in treating conditions such as excessive bleeding, exchange transfusions, and self-blood donation. Blood components, such as red blood cells, platelets, plasma, and white blood cells, find applications in treating anemia, trauma, surgery, cancer, and bleeding disorders. End-users in this market comprise hospitals, ambulatory surgical centers, and other healthcare facilities.

The blood and blood components market research report is one of a series of new reports from The Business Research Company that provides blood and blood components market statistics, including blood and blood components industry global market size, regional shares, competitors with a blood and blood components market share, detailed blood and blood components market segments, market trends and opportunities, and any further data you may need to thrive in the blood and blood components industry. This blood and blood components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood and blood components market size has grown steadily in recent years. It will grow from $41.36 billion in 2024 to $43.2 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to increasing incidence of trauma and road accidents, increased aging population, increased earnings and standard of living, increased healthcare expenditure, and rising awareness about blood donation.

The blood and blood components market size is expected to see strong growth in the next few years. It will grow to $53.56 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to an increase in chronic diseases, government initiatives, and increasing demand for whole blood. Major trends in the forecast period include focusing on collaboration with other players, launching innovative products, focusing on research and development (R&D) activities, using IoT-based products to avoid the contamination of blood and blood components, and focusing on the management of blood transfusion.

The blood and blood components market is being propelled by the rising occurrence of trauma and road accidents. Traumas such as hemorrhage can significantly reduce blood volume, which the body cannot replace quickly enough. Moreover, road accidents result in substantial blood loss that requires immediate restoration. These circumstances necessitate the transfusion of blood and its components into patients. For example, in 2023, the Transport Accident Commission, an Australian government agency, reported that 295 people lost their lives on Victorian roads, representing a 22.4% increase (54 more fatalities) compared to 2022. Additionally, there were 261 fatal crashes, an increase of 22 (9%) from the 239 recorded the previous year. The rising prevalence of diseases and the growing number of road accidents and traumas are driving up the demand for blood, thereby fueling market growth.

The burgeoning prevalence of bleeding disorders is anticipated to further drive the expansion of the blood and blood components market. Bleeding disorders, encompassing conditions such as hemophilia, involve impaired blood clotting, leading to excessive or prolonged bleeding, even from minor injuries or spontaneously. Blood and its components play a pivotal role in treating these disorders by providing essential elements such as red blood cells, platelets, and clotting factors. These components can be transfused to supplement or replace deficient or dysfunctional elements in patients, thereby enhancing their clotting abilities and overall health. For instance, as per the Centers for Disease Control and Prevention (CDC) in July 2023, hemophilia A occurs in approximately one in 5,000 male births in the United States, with an estimated 400 babies born with hemophilia A each year. Moreover, the current estimate suggests that between 30,000 to 33,000 males are living with hemophilia in the United States. Hence, the rising incidence of bleeding disorders is a key driver fueling the growth of the blood and blood components market.

The prevailing trend in the blood and blood components market revolves around an increasing number of collaborations among industry players. Companies are opting for partnerships and collaborations to broaden their market reach, expand their customer base, and raise awareness within the industry. For instance, the American Red Cross partnered with HealthStream to introduce a new program targeting healthcare organizations. Additionally, the BloodCenter of Wisconsin collaborated with SysLogic Inc. to explore RFID technology's potential in enhancing patient safety during the collection and transfusion of blood products.

Key companies within the blood and blood component market are prioritizing the development of innovative technologies, notably an advanced precision blood typing process, aimed at averting complications during blood transfusion procedures. Precision blood typing involves a proprietary process employing cutting-edge techniques and technologies to accurately determine an individual's specific blood type, encompassing both blood group and subgroup, ensuring safe and precise blood or blood product transfusions. For instance, in April 2023, the San Diego Blood Bank, a US-based blood bank, launched its precision blood initiative. This initiative seeks to elevate the standard of care for blood transfusion patients by scaling the precision blood typing process. The program's overarching goal is to positively impact and potentially save lives by enhancing the standard of care for individuals requiring blood transfusions.

In October 2022, Pfizer, a leading U.S. pharmaceutical company, successfully acquired Global Blood Therapeutics for an undisclosed sum. This strategic acquisition enhances Pfizer's expertise in addressing sickle cell disease, aligning with the company's 30-year legacy. Global Blood Therapeutics, a U.S.-based developer specializing in treatments for blood diseases, particularly sickle cell disease, brings valuable assets to further bolster Pfizer's position in the field.

Major companies operating in the blood and blood components market include American Red Cross, The Japanese Red Cross Society, Canadian Blood Services, Australian Red Cross, and Vitalant, SANQUIN BLOOD SUPPLY FOUNDATION, New York Blood Center, Blood Bank of Alaska, Blood Centers of America, Xinjiang Deyuan Bioengineering, Harbin Pacific Biopharmaceutical, Southern Shuanglin Bio-Pharmacy, Beijing Tiantan Biological Products, Shanghai RAAS Blood Products, China Biologic Products, Hualan Biological Engineering, Biotest AG, Lorne Laboratories UK, LMB Germany, Bio Products Laboratory Ltd, Clinical Trials Laboratory Services (CTLS), Roche, Hemanext Inc, Kedrion Biopharma, KalVista Pharmaceuticals, Personal Genome, Cellphire, Inc., Immuno-Mycologics INC, CSL Behring, Nordson Corporation, Octapharma Canada Inc., Abbott Laboratories, Grifols, Nipro Medical Corporation, Becton, Dickinson and Company

North America was the largest region in the blood and blood components market in 2024. Western Europe was the second largest region in the global blood and blood components market analysis. The regions covered in the blood and blood components market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the blood and blood components market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The blood and blood components market consist of sales of red cells, platelets, plasms, cryoprecipitated AHF, and granulocytes. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood And Blood Components Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood and blood components market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood and blood components ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood and blood components market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Whole Blood, Blood Components
• 2) By Blood Components: Red Blood Cells, Platelets, Plasma, White Blood Cells
• 3) By End-User: Hospitals, Ambulatory Surgical Centers, Others
• 4) By Application: Anemia, Trauma and Surgery, Cancer Treatment, Bleeding Disorders
• Subsegments:
• 1) By Whole Blood: Donor Whole Blood; Autologous Whole Blood
• 2) By Blood Components: Red Blood Cells (RBCs); Platelets; Plasma; White Blood Cells (WBCs)
• Companies Mentioned: American Red Cross; The Japanese Red Cross Society; Canadian Blood Services; Australian Red Cross; and Vitalant
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood And Blood Components Market Characteristics

3. Blood And Blood Components Market Trends And Strategies

4. Blood And Blood Components Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Blood And Blood Components Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blood And Blood Components PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blood And Blood Components Market Growth Rate Analysis
• 5.4. Global Blood And Blood Components Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blood And Blood Components Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blood And Blood Components Total Addressable Market (TAM)

6. Blood And Blood Components Market Segmentation

• 6.1. Global Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Blood
• Blood Components
• 6.2. Global Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Red Blood Cells
• Platelets
• Plasma
• White Blood Cells
• 6.3. Global Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Others
• 6.4. Global Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anemia
• Trauma and Surgery
• Cancer Treatment
• Bleeding Disorders
• 6.5. Global Blood And Blood Components Market, Sub-Segmentation Of Whole Blood, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Donor Whole Blood
• Autologous Whole Blood
• 6.6. Global Blood And Blood Components Market, Sub-Segmentation Of Blood Components, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Red Blood Cells (RBCs)
• Platelets
• Plasma
• White Blood Cells (WBCs)

7. Blood And Blood Components Market Regional And Country Analysis

• 7.1. Global Blood And Blood Components Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blood And Blood Components Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood And Blood Components Market

• 8.1. Asia-Pacific Blood And Blood Components Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood And Blood Components Market

• 9.1. China Blood And Blood Components Market Overview
• 9.2. China Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood And Blood Components Market

• 10.1. India Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood And Blood Components Market

• 11.1. Japan Blood And Blood Components Market Overview
• 11.2. Japan Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood And Blood Components Market

• 12.1. Australia Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood And Blood Components Market

• 13.1. Indonesia Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood And Blood Components Market

• 14.1. South Korea Blood And Blood Components Market Overview
• 14.2. South Korea Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood And Blood Components Market

• 15.1. Western Europe Blood And Blood Components Market Overview
• 15.2. Western Europe Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood And Blood Components Market

• 16.1. UK Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood And Blood Components Market

• 17.1. Germany Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood And Blood Components Market

• 18.1. France Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood And Blood Components Market

• 19.1. Italy Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood And Blood Components Market

• 20.1. Spain Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood And Blood Components Market

• 21.1. Eastern Europe Blood And Blood Components Market Overview
• 21.2. Eastern Europe Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood And Blood Components Market

• 22.1. Russia Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood And Blood Components Market

• 23.1. North America Blood And Blood Components Market Overview
• 23.2. North America Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood And Blood Components Market

• 24.1. USA Blood And Blood Components Market Overview
• 24.2. USA Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood And Blood Components Market

• 25.1. Canada Blood And Blood Components Market Overview
• 25.2. Canada Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood And Blood Components Market

• 26.1. South America Blood And Blood Components Market Overview
• 26.2. South America Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood And Blood Components Market

• 27.1. Brazil Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood And Blood Components Market

• 28.1. Middle East Blood And Blood Components Market Overview
• 28.2. Middle East Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood And Blood Components Market

• 29.1. Africa Blood And Blood Components Market Overview
• 29.2. Africa Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood And Blood Components Market Competitive Landscape And Company Profiles

• 30.1. Blood And Blood Components Market Competitive Landscape
• 30.2. Blood And Blood Components Market Company Profiles
  • 30.2.1. American Red Cross Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. The Japanese Red Cross Society Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Canadian Blood Services Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Australian Red Cross Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. and Vitalant Overview, Products and Services, Strategy and Financial Analysis

31. Blood And Blood Components Market Other Major And Innovative Companies

• 31.1. SANQUIN BLOOD SUPPLY FOUNDATION
• 31.2. New York Blood Center
• 31.3. Blood Bank of Alaska
• 31.4. Blood Centers of America
• 31.5. Xinjiang Deyuan Bioengineering
• 31.6. Harbin Pacific Biopharmaceutical
• 31.7. Southern Shuanglin Bio-Pharmacy
• 31.8. Beijing Tiantan Biological Products
• 31.9. Shanghai RAAS Blood Products
• 31.10. China Biologic Products
• 31.11. Hualan Biological Engineering
• 31.12. Biotest AG
• 31.13. Lorne Laboratories UK
• 31.14. LMB Germany
• 31.15. Bio Products Laboratory Ltd

32. Global Blood And Blood Components Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood And Blood Components Market

34. Recent Developments In The Blood And Blood Components Market

35. Blood And Blood Components Market High Potential Countries, Segments and Strategies

• 35.1 Blood And Blood Components Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blood And Blood Components Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blood And Blood Components Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer